BioInvent Announces Publication of Data in Leading Cancer Journal Immunity
Go back to BioInvent Announces Publication of Data in Leading Cancer Journal Immunity| (NYSE: BINV) | Delayed: 42.31 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.31 | 52 Week High | $ | |||
| Open | $42.31 | 52 Week Low | $ | |||
| Day High | $42.31 | P/E | N/A | |||
| Day Low | $42.31 | EPS | $ | |||
| Volume | 105 | |||||
